TY - JOUR
T1 - Vessel fractional flow reserve (vFFR) for the assessment of stenosis severity
T2 - the FAST II study
AU - the FAST II Study Investigators
AU - Masdjedi, Kaneshka
AU - Tanaka, Nobuhiro
AU - Van Belle, Eric
AU - Porouchani, Sina
AU - Linke, Axel
AU - Woitek, Felix J.
AU - Bartorelli, Antonio L.
AU - Ali, Ziad A.
AU - den Dekker, Wijnand K.
AU - Wilschut, Jeroen
AU - Diletti, Roberto
AU - Zijlstra, Felix
AU - Boersma, Eric
AU - Van Mieghem, Nicolas M.
AU - Spitzer, Ernest
AU - Daemen, Joost
N1 - Publisher Copyright:
© Europa Digital & Publishing 2022. All rights reserved.
PY - 2022/4
Y1 - 2022/4
N2 - Background: Fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) is superior to angiography-guided PCI. The clinical uptake of FFR has been limited, however, by the need to advance a wire in the coronary artery, the additional time required and the need for hyperaemic agents which can cause patient discomfort. FFR derived from routine coronary angiography eliminates these issues. Aims: The aim of this study was to assess the diagnostic performance and accuracy of three-dimensional quantitative coronary angiography (3D-QCA)-based vessel FFR (vFFR) compared to pressure wire-based FFR (≤0.80). Methods: The FAST II (Fast Assessment of STenosis severity) study was a prospective observational multicentre study designed to evaluate the diagnostic accuracy of vFFR compared to the reference standard (pressure wire-based FFR ≤0.80). A total of 334 patients from six centres were enrolled. Both site-determined and blinded independent core lab vFFR measurements were compared to FFR. Results: The core lab vFFR was 0.83±0.09 and pressure wire-based FFR 0.83±0.08. A good correlation was found between core lab vFFR and pressure wire-based FFR (R=0.74; p<0.001; mean bias 0.0029±0.0642). vFFR had an excellent diagnostic accuracy in identifying lesions with an invasive wire-based FFR ≤0.80 (area under the curve [AUC] 0.93; 95% confidence interval [CI]: 0.90-0.96; p<0.001). Positive predictive value, negative predictive value, diagnostic accuracy, sensitivity and specificity of vFFR were 90%, 90%, 90%, 81% and 95%, respectively. Conclusions: 3D-QCA-based vFFR has excellent diagnostic performance to detect FFR ≤0.80.
AB - Background: Fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) is superior to angiography-guided PCI. The clinical uptake of FFR has been limited, however, by the need to advance a wire in the coronary artery, the additional time required and the need for hyperaemic agents which can cause patient discomfort. FFR derived from routine coronary angiography eliminates these issues. Aims: The aim of this study was to assess the diagnostic performance and accuracy of three-dimensional quantitative coronary angiography (3D-QCA)-based vessel FFR (vFFR) compared to pressure wire-based FFR (≤0.80). Methods: The FAST II (Fast Assessment of STenosis severity) study was a prospective observational multicentre study designed to evaluate the diagnostic accuracy of vFFR compared to the reference standard (pressure wire-based FFR ≤0.80). A total of 334 patients from six centres were enrolled. Both site-determined and blinded independent core lab vFFR measurements were compared to FFR. Results: The core lab vFFR was 0.83±0.09 and pressure wire-based FFR 0.83±0.08. A good correlation was found between core lab vFFR and pressure wire-based FFR (R=0.74; p<0.001; mean bias 0.0029±0.0642). vFFR had an excellent diagnostic accuracy in identifying lesions with an invasive wire-based FFR ≤0.80 (area under the curve [AUC] 0.93; 95% confidence interval [CI]: 0.90-0.96; p<0.001). Positive predictive value, negative predictive value, diagnostic accuracy, sensitivity and specificity of vFFR were 90%, 90%, 90%, 81% and 95%, respectively. Conclusions: 3D-QCA-based vFFR has excellent diagnostic performance to detect FFR ≤0.80.
KW - QCA
KW - fractional flow reserve
KW - other technique
UR - http://www.scopus.com/inward/record.url?scp=85125526188&partnerID=8YFLogxK
U2 - 10.4244/EIJ-D-21-00471
DO - 10.4244/EIJ-D-21-00471
M3 - Article
C2 - 34647890
AN - SCOPUS:85125526188
SN - 1774-024X
VL - 17
SP - 1498
EP - 1505
JO - EuroIntervention
JF - EuroIntervention
IS - 18
ER -